New Treatment Options for Parkinson's Disease Show Promise
Mardi 01 Juillet 2008 - 09:29 - 6 mois, 1 semaine depuis
-
Presse spécialisée
-
Medscape family medicine
Phase 2 results with a new nonergot compound called pardoprunox appear promising, but adverse effects may be an issue. In a separate study, transdermal delivery of a levodopa prodrug increased levodopa levels in a small number of patients, raising hopes for a levodopa patch. Medscape Medical News